MCED Testing Enters New Diagnostic Realms
Elie Dolgin • August 4, 2023
Real-world performance data and trial results in symptomatic individuals continue to validate the promise of screening for multiple cancers with a single blood draw. However, some worry about the performance of GRAIL's commercially available multicancer early detection test in certain high-risk groups that were not the focus of early clinical development efforts.
Continue reading at Cancer Discovery.
This ancient oddball fills a major gap in the fossil record.
Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve drainage from the brain. Now it is entering trials worldwide.